NCT07202871View on ClinicalTrials.gov

A Study of How the Body Absorbs LY3537031

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

September 30, 2026

Conditions

Healthy

Interventions

DRUG

LY3537031

Administered SC

DRUG

LY3537031

Administered IV

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY